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An a⁄liation of the second author was omitted. Ana C.S.
Monteiro is a⁄liated to the Instituto de Biof|¤sica Carlos Cha-
gas Filho, Bloco G, CCS, Universidade Federal do Rio de
Janeiro, Ilha do Funda‹o, Rio de Janeiro, Brazil ^ CEP
21990-400.
Abstract. The ¢rst sentence should state: ‘Chagasin, a pro-
tein from Trypanosoma cruzi, is the ¢rst member of a new
family of tight-binding cysteine protease inhibitors [Monteiro,
A.C.S., Abrahamson, M., Lima, A.P.C., Vannier-Santos,
M.A. and Scharfstein, J. (2001) J. Cell Sci., in press]’.
1. Introduction. The second paragraph should state: ‘A
search for cystatin-type inhibitors in T. cruzi has led to the
isolation of a cDNA clone that codes for a novel protein,
named chagasin, expressed in all life stages of the parasite,
which acts as a tight-binding inhibitor of cruzipain and other
cysteine proteases [4]’.
2. Materials and methods. The ¢rst paragraph should state:
‘The chagasin cDNA clone, Tc18 (GenBank/EMBL accession
number AJ299433) was isolated after screening an epimasti-
gote a Vgt11 cDNA expression library by ligand binding with
carboxymethylated papain and cruzipain. High-level expres-
sion in E. coli indicated that the recombinant protein acts as
tight-binding cysteine protease inhibitor [4]’.
3. Results. In the ¢rst paragraph, p. 43, the data on true Ki
values should be deleted. Instead, the sentence should state:
‘Of 13 overlapping 15-residue peptides spanning the chagasin
sequence, six inhibited cruzipain with true Ki values in the low
micromolar range (A.C.S. Monteiro et al., unpublished data)’.
References. The citation [4] Monteiro, A.C.S., Scharfstein,
J., Abrahamson, M. and Grossi de Sa¤, M.F. (2000) in: Abstr.
6th Int. Congress Plant Mol. Biol., pp. S16^S27 should be
replaced with ‘[4] Monteiro, A.C.S, Abrahamson, M., Lima,
A.P.C., Vannier-Santos, M.A. and Scharfstein, J. (2001) J. Cell
Sci. (in press)’.
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